🔗 Share this article

Acclaimed R&B singer D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic malignancy.

“The shining star of our family has faded away for us in this life,” his relatives stated. “After a prolonged and brave battle with the disease, we are heartbroken to declare that D’Angelo, known to his fans around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on music with his innovative modern soul style and partnerships with high-profile artists.

He released his debut album, “Brown Sugar,” in 1995 to instant praise. The album reached No. 4 on Billboard’s Top R&B Albums chart, went platinum later that year, and received several award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that boosted his artistic journey into the stratosphere. The record debuted at No. 1 on both Billboard’s Top R&B Albums chart and the main album chart. He won two Grammys: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a sex symbol, albeit a hesitant one, in the public consciousness. The intimate portrayal showed the artist, notably stripped down to his midsection, singing directly into the camera.

D’Angelo stepped back from the public eye after putting out Voodoo and publicly struggled with drugs and alcohol. In 2005, he was involved in a serious car crash that put him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his lasting popularity with a further top chart entry on the soul music rankings and a Grammy for Top R&B Record.

Once more, in his own enigmatic fashion, D’Angelo made only a few public appearances in the subsequent period.

The musician was announced as a top act for the 2025 music event, but his performance was canceled, citing an “unexpected health issue.”

Even though information is limited about D’Angelo’s health in the months before his passing, he had apparently been hospitalized for months and in hospice for a fortnight.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic cancer, one of the most deadly and hardest to prevent forms of the illness, on a brilliant talent whose life was cut short.

“We are grieved that he can only provide dear memories with his family, but we are forever thankful for the heritage of deeply emotional music he has left us,” his kin expressed.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic malignancy impacts the pancreas, a tiny gland that generates the hormone insulin and is vital in breaking down food, among additional roles. The size and location of the organ in the body make it more difficult to identify malignancy.

Even though pancreatic cancer accounts for only about 3% of cancer diagnoses each year in the U.S., it is causes seven percent of malignancy fatalities.

Nearly 70,000 individuals will be found to have this condition and about fifty-two thousand will die of the disease in the year 2025.

“Pancreatic cancer is one of the deadliest cancers, with an aggressive tumor and dismal outcomes. We have limited and poor treatment options, and a smaller window to make a meaningful impact on the well-being of people,” noted a medical oncologist.

Since this disease rarely causes early symptoms, it’s frequently identified only once the disease is late-stage. Although a individual has symptoms they are usually nonspecific and may be confused with a number of common illnesses.

“Currently, there is no effective method to identify pancreatic cancer in the early stages, apart from paying attention to physical changes and consulting your physician if there are new or unusual symptoms,” explained a medical director.

Common symptoms of pancreatic cancer encompass:

• abdominal or lower back pain
• reduced body mass
• jaundice
• reduced hunger
• dark urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• nausea

At 51 years old, D’Angelo’s demise is an outlier, as pancreatic cancer is most common in individuals in the 65 to 75 age bracket. However, numerous malignancies, such as pancreatic cancer, have become more common in younger adults.

“This disease identified before the age of 50 is considered uncommon, yet concerningly, clinicians are noticing a rising count of younger individuals affected by this disease,” commented a expert.

Family History Impacts Disease Probability

In the absence of reliable screening tools for pancreatic cancer, professionals stressed the importance of understanding your relatives’ cancer history. Some risk factors, such as tobacco use and excess weight also have an influence in the onset of this disease.

African Americans have the greatest occurrence of pancreatic cancer in the U.S. and are more prone to be diagnosed with inoperable cancer.

“The first step toward reducing one’s risk of this condition is understanding personal risk factors. Individuals should examine their genetic background, genetic background, and health issues, such as diabetes, chronic pancreatitis, or obesity that may raise their vulnerability,” advised a specialist.

Hereditary risk factors are associated with as much as ten percent of all pancreatic cancer cases. If a relative in your family has had this disease, you may want to consider DNA analysis.

“For people with a relative’s background of this condition or those carrying high risk DNA changes, screening may involve sophisticated scans such as magnetic resonance imaging (MRI) or internal ultrasound to find initial alterations in the organ,” he clarified.

For those wishing to lower their chance, habit adjustments may make a difference. The best action you can take to lower your risk of this disease is to quit smoking, and if you don’t smoke, stay away altogether.

Excessive drinking is associated with pancreas inflammation, a contributing element for this malignancy, so reducing or avoiding alcohol may assist lower your chance.

Controlling your body mass or losing weight may also help reduce your risk. Individuals with obesity are twenty percent more prone to develop this disease. This malignancy also is more frequent in people with blood sugar issues, and reducing weight can also reduce the chance of type 2 diabetes.

Despite pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and more recent mixed drug treatments. There are emerging precision medicines that are already showing results,” said a specialist.

For numerous individuals, however, awareness about this rare but {dev